1. Papaioannou, V.E. & Fox, J.G. Efficacy of tribromoethanol anesthesia in mice. Lab. Anim. Sci. 43(2), 189–192 (1993).
2. Lieggi, C. et al. Efficacy and safety of stored and newly prepared tribromoethanol in ICR mice. Contemp. Top. Lab. Anim. Sci. 44(1), 17–22 (2005).
3. Reid, W.C., Carmichael, K.P., Srinivas, S. & Bryant, J. Pathologic changes associated with use of tribromoethanol (Avertin) in the Sprague Dawley rat. Lab. Anim. Sci. 49(6), 665–667 (1999).
4. Thompson, J.S. et al. Early effects of tribromoethanol, ketamine/xylazine, pentobarbital, and isoflurane anesthesia on hepatic and lymphoid tissue in ICR mice. Comp. Med. 52(1), 63–67 (2002).
5. Zeller, W., Meier, G., Burki, K. & Panoussis, B. Adverse effects of tribromoethanol as used in the production of transgenic mice. Lab. Anim. 32(4), 407–413 (1998).